Literature DB >> 8786410

Functionality map analysis of the active site cleft of human thrombin.

P D Grootenhuis1, M Karplus.   

Abstract

The Multiple Copy Simultaneous Search methodology has been used to construct functionality maps for an extended region of human thrombin, including the active site. This method allows the determination of energetically favorable positions and orientations for functional groups defined by the user on the three-dimensional surface of a protein. The positions of 10 functional group sites are compared with those of corresponding groups of four thrombin-inhibitor complexes. Many, but not all features, of known thrombin inhibitors are reproduced by the method. The results indicate that certain aspects of the binding modes of these inhibitors are not optimal. In addition, suggestions are made for improving binding by interaction with functional group sites on the thrombin surface that are not used by the thrombin inhibitors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786410     DOI: 10.1007/bf00124460

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  32 in total

Review 1.  A strategy for a rational approach to designing synthetic selective inhibitors.

Authors:  A Hijikata-Okunomiya; S Okamoto
Journal:  Semin Thromb Hemost       Date:  1992-01       Impact factor: 4.180

Review 2.  Pharmacologic aspects of the development of selective synthetic thrombin inhibitors as anticoagulants.

Authors:  J Hauptmann; F Markwardt
Journal:  Semin Thromb Hemost       Date:  1992       Impact factor: 4.180

3.  Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.

Authors:  E Skrzypczak-Jankun; V E Carperos; K G Ravichandran; A Tulinsky; M Westbrook; J M Maraganore
Journal:  J Mol Biol       Date:  1991-10-20       Impact factor: 5.469

4.  Stability and specificity of protein-protein interactions: the case of the trypsin-trypsin inhibitor complexes.

Authors:  J Janin; C Chothia
Journal:  J Mol Biol       Date:  1976-01-15       Impact factor: 5.469

5.  The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution.

Authors:  P D Martin; W Robertson; D Turk; R Huber; W Bode; B F Edwards
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

Review 6.  Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile.

Authors:  C Tapparelli; R Metternich; C Ehrhardt; N S Cook
Journal:  Trends Pharmacol Sci       Date:  1993-10       Impact factor: 14.819

7.  Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.

Authors:  A Zdanov; S Wu; J DiMaio; Y Konishi; Y Li; X Wu; B F Edwards; P D Martin; M Cygler
Journal:  Proteins       Date:  1993-11

8.  Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl++ +) sulfonyl]-l-arginyl)]-2-piperidinecarboxylic acid.

Authors:  R Kikumoto; Y Tamao; T Tezuka; S Tonomura; H Hara; K Ninomiya; A Hijikata; S Okamoto
Journal:  Biochemistry       Date:  1984-01-03       Impact factor: 3.162

9.  Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.

Authors:  M Jetten; C A Peters; A Visser; P D Grootenhuis; J W van Nispen; H C Ottenheijm
Journal:  Bioorg Med Chem       Date:  1995-08       Impact factor: 3.641

10.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

View more
  7 in total

1.  Design of dimerization inhibitors of HIV-1 aspartic proteinase: a computer-based combinatorial approach.

Authors:  A Caflisch; H J Schramm; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2000-02       Impact factor: 3.686

2.  Comparison of two implementations of the incremental construction algorithm in flexible docking of thrombin inhibitors.

Authors:  R M Knegtel; D M Bayada; R A Engh; W von der Saal; V J van Geerestein; P D Grootenhuis
Journal:  J Comput Aided Mol Des       Date:  1999-03       Impact factor: 3.686

3.  De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks.

Authors:  G Schneider; M L Lee; M Stahl; P Schneider
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

4.  Evaluation of designed ligands by a multiple screening method: application to glycogen phosphorylase inhibitors constructed with a variety of approaches.

Authors:  S S So; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2001-07       Impact factor: 3.686

5.  Quantum and molecular dynamics study for binding of macrocyclic inhibitors to human alpha-thrombin.

Authors:  Emilia L Wu; Ye Mei; KeLi Han; John Z H Zhang
Journal:  Biophys J       Date:  2007-03-23       Impact factor: 4.033

6.  Active-site-directed 3D database searching: pharmacophore extraction and validation of hits.

Authors:  D E Clark; D R Westhead; R A Sykes; C W Murray
Journal:  J Comput Aided Mol Des       Date:  1996-10       Impact factor: 3.686

7.  Computational combinatorial ligand design: application to human alpha-thrombin.

Authors:  A Caflisch
Journal:  J Comput Aided Mol Des       Date:  1996-10       Impact factor: 3.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.